These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32314485)

  • 1. Outcome for Pediatric Recipients of Macrosteatotic Liver Grafts From Living Donors.
    Irie R; Nakazawa A; Sakamoto S; Takeda M; Yanagi Y; Shimizu S; Uchida H; Fukuda A; Kasahara M
    Liver Transpl; 2020 Jul; 26(7):899-905. PubMed ID: 32314485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
    Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.
    Chok KSH; Chan ACY; Fung JYY; Dai WC; Cheung TT; Lo CM
    Hepatol Int; 2017 Nov; 11(6):517-522. PubMed ID: 28936686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia.
    Sanada Y; Kawano Y; Miki A; Aida J; Nakamura K; Shimomura N; Ishikawa N; Arai T; Hirata Y; Yamada N; Okada N; Wakiya T; Ihara Y; Urahashi T; Yasuda Y; Takubo K; Mizuta K
    Transpl Int; 2014 Apr; 27(4):383-90. PubMed ID: 24472036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic benefit of maternal donors in pediatric living donor liver transplantation.
    Kim MH; Akbari O; Genyk Y; Kohli R; Emamaullee J
    Pediatr Transplant; 2019 Nov; 23(7):e13560. PubMed ID: 31402535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsteatosis may not interact with macrosteatosis in living donor liver transplantation.
    Han S; Ha SY; Park CK; Joh JW; Kwon CH; Kwon GY; Kim G; Gwak MS; Jeong WK; Ko JS
    J Hepatol; 2015 Mar; 62(3):556-62. PubMed ID: 25450710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation.
    Núñez K; Hamed M; Fort D; Bruce D; Thevenot P; Cohen A
    World J Transplant; 2020 May; 10(5):117-128. PubMed ID: 32864357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of failure in living donor liver transplantation: differential outcomes in children and adults.
    Goldstein MJ; Salame E; Kapur S; Kinkhabwala M; LaPointe-Rudow D; Harren N P P; Lobritto SJ; Russo M; Brown RS; Cataldegirmen G; Weinberg A; Renz JF; Emond JC
    World J Surg; 2003 Mar; 27(3):356-64. PubMed ID: 12607066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor liver transplantation in children with cholestatic liver disease: a single-center experience.
    Mizuta K; Urahashi T; Ihara Y; Sanada Y; Wakiya T; Yamada N; Okada N; Egami S; Hishikawa S; Hyodo M; Sakuma Y; Fujiwara T; Kawarasaki H; Yasuda Y
    Transplant Proc; 2012 Mar; 44(2):469-72. PubMed ID: 22410047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
    Kasahara M; Katono M; Schlegel A; Kubota T; Nakazato Y; Uchida H; Shimizu S; Yanagi Y; Takeda M; Fukuda A; Sakamoto S
    Pediatr Transplant; 2019 Dec; 23(8):e13578. PubMed ID: 31535772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases.
    Hong JC; Yersiz H; Farmer DG; Duffy JP; Ghobrial RM; Nonthasoot B; Collins TE; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2009 May; 208(5):682-9; discusion 689-91. PubMed ID: 19476815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis.
    Altshuler PJ; Dang H; Frank AM; Shah AP; Glorioso J; Zhan T; Rios Diaz A; Shaheen O; Ramirez CB; Maley WR; Bodzin AS
    Liver Transpl; 2022 Apr; 28(4):623-635. PubMed ID: 34564931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Q-FISH measurement of hepatocyte telomere lengths in donor liver and graft after pediatric living-donor liver transplantation: donor age affects telomere length sustainability.
    Kawano Y; Ishikawa N; Aida J; Sanada Y; Izumiyama-Shimomura N; Nakamura K; Poon SS; Matsumoto K; Mizuta K; Uchida E; Tajiri T; Kawarasaki H; Takubo K
    PLoS One; 2014; 9(4):e93749. PubMed ID: 24727734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live donor liver transplantation for fulminant hepatic failure in children.
    Liu CL; Fan ST; Lo CM; Tam PK; Saing H; Wei WI; Yong BH; Tsoi NS; Wong J
    Liver Transpl; 2003 Nov; 9(11):1185-90. PubMed ID: 14586880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation in 43 children with biliary atresia: a single-center experience from the mainland of China.
    Zhu JJ; Xia Q; Zhang JJ; Xue F; Chen XS; Li QG; Xu N
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):250-5. PubMed ID: 22672817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.